Introduction
The article “Neuropsychological decline after cath- eter ablation of atrial fibrillation” by Schwarz et al. is the first publication that focused on cognitive side effects of elective circumferential pulmonary vein isolation (PVI).[1] Adverse neuropsychological changes after left atrial catheter ablation, as report- ed in this paper, were found in verbal memory and the result, conjoined with ischemic brain lesions, might represent cerebral side-effects of the ablation procedure.
Catheter ablation is recommended as a second-line therapy to treat recurrent symptomatic atrial fibril- lation (AF) in patients who remain refractory to conventional antiarrhythmic therapy.[2] However, stroke, transient ischemic attacks (TIA) and other embolic events due to thrombogenicity of the pro- cedure are recognized side-effects during and af- ter left atrial catheter ablation.[3,4] The incidence of stroke varies between less than 1% and 7%.[5] Ac- cording to a large multi-centre study, ischemic brain lesion (and myocardial damage) was the third most frequent cause of death, after cardiac tampon- ade - including irreversible pump-failure and atrio- esophageal fistulas.[6]
The underlying pathophysiology of neurologi- cal side-effects is most likely related to embolism. Thrombus formation during and after catheter ab- lation might result from platelet and coagulation system activation either directly at the catheter ma- terial or at the site of endothelial lesions that are caused by the ablation procedure.[7,8] Transcranial Doppler monitoring indicated that several thou- sand micro-embolic signals (MES) can be detected within the basal cerebral arteries during the abla- tion process.[9] The micro-embolic load of patients undergoing AF ablation is therefore comparable to those subjected to major cardiac surgery (i.e. bypass surgery or valve replacement). Since cardiac sur gery can cause long-lasting neuropsychological changes and cerebral micro-embolism has been shown to play an important role in this context,[10] it is assumable that left atrial ablation might lead to neuropsychological deficits similarly to major cardiac surgery.
In the study of Schwarz et all . 23 patients with re- current AF who underwent elective PVI were en- rolled. The primary endpoint was the neuropsy- chological outcome 3 months after intervention in contrast to the results of non-AF controls (n =23) without ablation and in covariance of baseline performance. Cerebral diffusion-weighted mag- netic resonance imaging (DWI) was performed in 21 AF-patients at baseline, 2-4 days and 3 months after intervention.
New ischemic brain lesions were detected in 3/21 patients (14.3%) on DWI shortly after the inter- vention. In one patient, a territorial middle cere- bral artery infarct occurred with severe clinical symptoms. This patient was excluded from cog- nitive follow-up assessment. The other two pa- tients presented small and clinically silent brain lesions. It is assumable that the small ischemic brain lesions, detected on DWI might represent the “tip of iceberg” only, and other micro-lesion were undetectable by state-of-the-art magnetic resonance imaging.
In contrast to the control group and in covari- ance of baseline performance, the ablation group showed worse neuropsychological outcome in verbal memory tests (p<.001). Overall 56.5% of ablation patients deteriorated (at least mildly) from their baseline values in verbal memory, as compared to 17.4% of controls. Most controls, however, showed improved performance in this memory test, due to practice effects.
The reported data are important, because they support the risk apprehension of catheter abla- tion of atrial fibrillation and identify a hitherto unknown neurological side-effect of this proce- dure. Although the memory deficits reported were not severe and did not appear to affect the activities of daily living in a significant manner, the adverse effect needs to be taken into account in the consideration of the pros and cons for PVI. Further studies with larger sample size, longer observation time and the inclusion of cogni- tive assessment, sensitive DWI and transcranial Doppler sonography (to detect cerebral micro- embolism) are required to determine an overall risk-benefit analysis of ablation and to better understand the underlying pathophysiology of side-effects.
References
- 1.Schwarz Niko, Kuniss Malte, Nedelmann Max, Kaps Manfred, Bachmann Georg, Neumann Thomas, Pitschner Heinz-Friedrich, Gerriets Tibo. Neuropsychological decline after catheter ablation of atrial fibrillation. Heart Rhythm. 2010 Dec;7 (12):1761–7. doi: 10.1016/j.hrthm.2010.07.035. [DOI] [PubMed] [Google Scholar]
- 2.Fuster Valentin, Rydén Lars E, Cannom David S, Crijns Harry J, Curtis Anne B, Ellenbogen Kenneth A, Halperin Jonathan L, Le Heuzey Jean-Yves, Kay G Neal, Lowe James E, Olsson S Bertil, Prystowsky Eric N, Tamargo Juan Luis, Wann Samuel, Smith Sidney C, Jacobs Alice K, Adams Cynthia D, Anderson Jeffery L, Antman Elliott M, Hunt Sharon Ann, Nishimura Rick, Ornato Joseph P, Page Richard L, Riegel Barbara, Priori Silvia G, Blanc Jean-Jacques, Budaj Andrzej, Camm A John, Dean Veronica, Deckers Jaap W, Despres Catherine, Dickstein Kenneth, Lekakis John, McGregor Keith, Metra Marco, Morais Joao, Osterspey Ady, Zamorano José Luis. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J. Am. Coll. Cardiol. 2006 Aug 15;48 (4):854–906. doi: 10.1016/j.jacc.2006.07.009. [DOI] [PubMed] [Google Scholar]
- 3.Marrouche Nassir F, Dresing Thomas, Cole Christopher, Bash Dianna, Saad Eduardo, Balaban Krzysztof, Pavia Stephen V, Schweikert Robert, Saliba Walid, Abdul-Karim Ahmed, Pisano Ennio, Fanelli Raffaele, Tchou Patrick, Natale Andrea. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J. Am. Coll. Cardiol. 2002 Aug 07;40 (3):464–74. doi: 10.1016/s0735-1097(02)01972-1. [DOI] [PubMed] [Google Scholar]
- 4.Cappato Riccardo, Calkins Hugh, Chen Shih-Ann, Davies Wyn, Iesaka Yoshito, Kalman Jonathan, Kim You-Ho, Klein George, Packer Douglas, Skanes Allan. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005 Mar 08;111 (9):1100–5. doi: 10.1161/01.CIR.0000157153.30978.67. [DOI] [PubMed] [Google Scholar]
- 5.Rodgers M, McKenna C, Palmer S, Chambers D, Van Hout S, Golder S, Pepper C, Todd D, Woolacott N. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation. Health Technol Assess. 2008 Nov;12 (34):iii–iv, xi-xiii, 1-198. doi: 10.3310/hta12340. [DOI] [PubMed] [Google Scholar]
- 6.Cappato Riccardo, Calkins Hugh, Chen Shih-Ann, Davies Wyn, Iesaka Yoshito, Kalman Jonathan, Kim You-Ho, Klein George, Natale Andrea, Packer Douglas, Skanes Allan. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J. Am. Coll. Cardiol. 2009 May 12;53 (19):1798–803. doi: 10.1016/j.jacc.2009.02.022. [DOI] [PubMed] [Google Scholar]
- 7.Lee D S, Dorian P, Downar E, Burns M, Yeo E L, Gold W L, Paquette M, Lau W, Newman D M. Thrombogenicity of radiofrequency ablation procedures: what factors influence thrombin generation? Europace. 2001 Jul;3 (3):195–200. doi: 10.1053/eupc.2001.0167. [DOI] [PubMed] [Google Scholar]
- 8.Lickfett Lars, Hackenbroch Matthias, Lewalter Thorsten, Selbach Stephanie, Schwab Jörg O, Yang Alexander, Balta Osman, Schrickel Jan, Bitzen Alexander, Lüderitz Berndt, Sommer Torsten. Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J. Cardiovasc. Electrophysiol. 2006 Jan;17 (1):1–7. doi: 10.1111/j.1540-8167.2005.00279.x. [DOI] [PubMed] [Google Scholar]
- 9.Sauren Loes D, VAN Belle Yves, DE Roy Luc, Pison Laurent, LA Meir Mark, VAN DER Veen Frederick H, Crijns Harry J, Jordaens Luc, Mess Werner H, Maessen Jos G. Transcranial measurement of cerebral microembolic signals during endocardial pulmonary vein isolation: comparison of three different ablation techniques. J. Cardiovasc. Electrophysiol. 2009 Oct;20 (10):1102–7. doi: 10.1111/j.1540-8167.2009.01509.x. [DOI] [PubMed] [Google Scholar]
- 10.Gerriets Tibo, Schwarz Niko, Sammer Gebhard, Baehr Jeanette, Stolz Erwin, Kaps Manfred, Kloevekorn Wolf-Peter, Bachmann Georg, Schönburg Markus. Protecting the brain from gaseous and solid micro-emboli during coronary artery bypass grafting: a randomized controlled trial. Eur. Heart J. 2010 Feb;31 (3):360–8. doi: 10.1093/eurheartj/ehp178. [DOI] [PubMed] [Google Scholar]
